Avalyn Pharma

Developer of therapies for the treatment of Idiopathic Pulmonary Fibrosis

placeSeattle, Washington, United States calendar_todayFounded 2011 groups24 employees language avalynpharma.com

Registered entities

Social engagement

Social engagement: 9.2K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

24 investors on record; lead investors include F-Prime Capital, Norwest, Edmond de Rothschild, Perceptive Advisors.

Investor typeCountShare
Venture capital1354%
Private equity313%
Accelerator & incubator14%
Bank & private debt28%
Other / undisclosed521%

Hiring activity

Hires occasionally

1 role tracked across 1 of the last 12 months

20 Nov 2025 · Director, Supply Chain · Boston

30 Aug 2025 · Senior Clinical Data Manager · Cambridge

Based on job postings tracked across public sources.

Recent activity

17 Jun 2026
Milestone
regulatory
4 Jun 2026
Event
Pulmonary Clinical Trials (PCT) Workshop
27 May 2026
Event
Jefferies Global Healthcare Conference
Coming soon